ARCHIVES

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

University Fires Bezwoda For Scientific Misconduct.

March 17, 2000

Cooperative Group Chairmen Told They Must Do Their Own Planning, Will Get Funds Increase

September 26, 1975

Obituary: Selma Schimmel, Founder of Vital Options, Dies of Cancer

May 23, 2014

Emory Cancer Experiment Launched Into Space

January 17, 2003

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

September 13, 1996